https://www.healthline.com/health/cancer/immunotherapy-vs-chemotherapy
Immunotherapy and chemotherapy are two commonly used cancer treatments. Both types of therapy involve the use of drugs to stop the growth of cancer cells. Although they have the same goal, the way

https://www.cancerresearch.org/blog/june-2016/difference-cancer-immunotherapy-and-chemotherapy
Immunotherapy vs. chemotherapy: Side effects. In order to destroy cancerous tumors, chemotherapy is intended to attack rapidly dividing cells within the body, which may include both cancerous and non-cancerous cells, such as hair follicles and the lining of the gut. These attacks on healthy cells may causes some of chemotherapy's more well

https://www.verywellhealth.com/chemotherapy-vs-immunotherapy-5324541
Summary. Chemotherapy and immunotherapy are both used in treating cancer. They help to kill cancer cells in different ways, and may be used together in some people. There are side effects to both treatments. It's important to discuss the potential side effects with your treatment team.

https://www.medicalnewstoday.com/articles/immunotherapy-vs-chemotherapy
Summary. Immunotherapy and chemotherapy are common cancer treatments. Both use drugs to stop the cancer from growing, but they achieve this in different ways. Immunotherapy enhances the immune

https://www.cancercenter.com/community/blog/2022/02/whats-the-difference-chemotherapy-immunotherapy
Chemotherapy kills fast-growing cells—both cancerous and non-cancerous—in the body. Immunotherapy helps the immune system do a better job of identifying cancer cells so it can attack and kill them. "Chemotherapy is a reactive approach. There's a fast-growing cancer cell in your body, so you want to stop the fast-growing cells.

https://www.cancerresearch.org/what-is-immunotherapy
Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body's own immune system to prevent, control, and eliminate cancer. Cancer immunotherapy comes in a variety of forms, including targeted antibodies, cancer vaccines, adoptive cell transfer, tumor-infecting viruses, checkpoint

https://www.goodrx.com/conditions/cancer/immunotherapy-vs-chemotherapy
Chemotherapy medications target various phases of the cell cycle. They help treat cancer by interfering with — or stopping — different parts of the cell cycle. This can slow down a cancer's growth and help make it go away. But, sadly, traditional chemotherapy medications aren't specific to cancer cells. They can also hurt healthy cells.

https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.. Immunotherapy is a type of biological therapy.Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer.

https://www.nebraskamed.com/cancer/are-immunotherapy-and-chemotherapy-the-same-thing-how-cancer-treatments-work
Chemotherapy, immunotherapy, targeted therapy, and hormone therapy are just a few of the treatments we use to treat cancer. Many of these cancer treatments can be combined with others like cancer surgery and radiation therapy. Every person's journey through cancer is different. Your oncology team will help you sort through the best therapies

https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/what-is-immunotherapy.html
Immunotherapy is treatment that uses certain parts of a person's immune system to fight diseases such as cancer. This can be done in a couple of ways: Stimulating, or boosting, the natural defenses of your immune system so it works harder or smarter to find and attack cancer cells. Making substances in a lab that are just like immune system

https://share.upmc.com/2020/10/chemotherapy-vs-immunotherapy/
While chemotherapy fights the cancer directly, immunotherapy stimulates the immune system to work harder and fight the cancer. "When patients receive chemotherapy for metastatic cancer, they must continue chemotherapy to have benefit," says Moon Fenton, MD, a medical oncologist and hematologist at UPMC Hillman Cancer Center in Beaver

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861781/
Immunotherapy versus chemotherapy. Systemic therapy for cancer consists of anti-cancer agents administered into the system to damage or destroy cancer cells and hence cancer growth, which can be either molecularly targeted therapy, biological therapy such as immunotherapy or cytotoxic therapy.

https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy.html
Immunotherapy. Immunotherapy is treatment that uses a person's own immune system to fight cancer. Immunotherapy can boost or change how the immune system works so it can find and attack cancer cells. If your treatment plan includes immunotherapy, knowing how it works and what to expect can often help you prepare for treatment and make informed

https://health.usnews.com/health-care/for-better/articles/immuno-oncology-and-immunotherapy-what-cancer-patients-should-know
Immunotherapy is different from chemotherapy or radiation because it focuses on fixing the immune system. Instead of directly targeting cancer cells, immunotherapy activates the body's own immune

https://www.mesothelioma.com/blog/immunotherapy-vs-chemotherapy/
Immunotherapy vs. Chemotherapy. Immunotherapy and chemotherapy are both cancer treatments. The main difference between immunotherapy and chemotherapy is the way these treatments target cancer. Chemotherapy uses drugs to target and kill fast-growing cells. Immunotherapy uses the body's immune system to slow, stop and kill cancerous cells.

https://www.medanta.org/patient-education-blog/difference-between-chemotherapy-and-immunotherapy-which-therapy-is-better-for-you
Effectiveness. The effectiveness of chemotherapy lasts as long as the patient continues the drugs. At the same time, immunotherapy is effective even after stopping the treatment. Immunotherapy increases the immune memory against cancer cells and prevents recurrence. This memory makes immunotherapy more durable and practical in the long term.

https://sunnybrook.ca/content/?page=immunotherapy-difference-chemotherapy
Chemotherapy attacks cancer cells directly by stopping their growth and spread. Chemotherapy can also affect healthy or normal cells. This can cause side effects like hair loss, mouth sores, or nausea. Chemotherapy and immunotherapy often have different side effects because they work in different ways. Immunotherapy can also affect normal cells

https://www.webmd.com/cancer/immunotherapy-risks-benefits
Immunotherapy may work when other treatments don't. Some cancers (like skin cancer ) don't respond well to radiation or chemotherapy but start to go away after immunotherapy. It can help other

https://ascopost.com/issues/october-10-2019/prolonged-long-term-survival-with-immunotherapy-vs-chemo-in-advanced-nsclc/
Immunotherapy vs Chemotherapy in Lung Cancer. Use of an immune checkpoint inhibitor vs chemotherapy prolonged survival in patients with advanced NSCLC, according to two abstracts presented at the 2019 World Conference on Lung Cancer. One study found a fivefold advantage in survival at 5 years with nivolumab vs chemotherapy in advanced NSCLC.

https://my.clevelandclinic.org/health/diseases/21096-immunotherapy-side-effects
Immunotherapy is a cancer treatment that uses your body's immune system to find and destroy cancer cells. Your immune system identifies harmful substances (including germs and abnormal cells) and destroys them to keep you healthy. But cancer cells are good at slipping past your immune system defenses. Cancer cells can multiply and spread

https://www.healio.com/hematology-oncology/learn-immuno-oncology/videos/immuno-oncology-video/immunotherapy-vs-chemotherapy
Morganna Freeman, DO, FACP, discusses how oncologists should talk to patients about the differences between immunotherapy vs. chemotherapy.

https://www.nejm.org/doi/full/10.1056/NEJMoa2400634
In that study, pathological responses to neoadjuvant chemotherapy were observed in only 7% of dMMR tumors. 6 Neoadjuvant immunotherapy has been tested across tumor types, 24-26 with compelling

https://www.verywellhealth.com/chemo-or-radiation-5201556
The decision about which one is used depends on the type, location, and spread of the cancer. Chemotherapy is a systemic treatment, while radiation therapy is often a localized treatment but may be systemic. Both can have side effects, which can differ by the patient and how the treatment is given.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095244/
Most patients with MPM are diagnosed with advanced disease due to its insidious onset and receive chemotherapy with or without immunotherapy or targeted therapy. For patients with early-stage MPM, a multimodality treatment is the gold-standard therapy, which includes surgery and chemotherapy, with or without radiotherapy.

https://www.training.seer.cancer.gov/treatment/chemotherapy/types/
They can be administered. Orally (oral chemotherapy - PO) Intramuscular injection (injected into a muscle - IM) Subcutaneous injection (injected under the skin - SubQ) Intravenous chemotherapy (into a vein- IV) Intrathecal chemotherapy (injected into the fluid around the spine). Two or more methods of administration may be used at the same time

https://www.livescience.com/health/cancer/immunotherapy-to-treat-cancer-gave-rise-to-2nd-cancer-in-extremely-rare-case
In an extremely rare case, a patient who received a cell-based cancer treatment later developed a second cancer that arose from the treatment itself. Known as chimeric antigen receptor (CAR) T

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791730
Exposures Radiation therapy and chemotherapy vs radiation therapy and ICI following craniotomy and microsurgical brain metastasis resection. Main ... and at least 2 cycles of either platinum-based chemotherapy or immunotherapy (Tables 1 and 2). Follow-up data were obtained until December 2021. Biomarkers and histopathological characteristics

https://www.astrazeneca.com/media-centre/press-releases/2024/imfinzi-approved-in-the-us-for-endometrial-cancer.html
Immunotherapy in combination with chemotherapy is emerging as a new standard of care in this setting, ... (Stage III-IV) usually have a much poorer prognosis, with the five-year survival rate falling to less than 20%. 5,6 Immunotherapy combined with chemotherapy is emerging as a new standard of care for advanced endometrial cancer,

https://www.businesswire.com/news/home/20240119767422/en/Opdivo-nivolumab-Plus-Yervoy-ipilimumab-Reduced-the-Risk-of-Disease-Progression-or-Death-by-79-Versus-Chemotherapy-in-Patients-with-Microsatellite-Instability-High-or-Mismatch-Repair-Deficient-Metastatic-Colorectal-Cancer-in-CheckMate--8HW-Trial
Opdivo plus Yervoy is the first dual immunotherapy regimen to demonstrate significant efficacy benefit compared to chemotherapy ... (95% CI: 38.4-NE) vs. 5.9 months in the chemotherapy arm (95% CI

https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-024-01848-z
Additionally, it is possible that peripheral blood T cell dynamics during chemotherapy + / − immunotherapy may be more informative than isolated baseline values (the only available in our study). Indeed, it has been suggested that peripheral blood cytotoxic T cell signatures at the end of NAC may be associated with long-term outcomes among